Oceanix™ / TetraSOD® (Tetraselmis chuii Marine Microalgae — Fitoplancton Marino)

Tetraselmis chuii
Evidence Level
Moderate
6 Clinical Trials
8 Documented Benefits
3/5 Evidence Score

Oceanix™ is the name Lonza used when it launched this marine phytoplankton ingredient in the US and Canada in 2019. The ingredient is TetraSOD®, freeze-dried Tetraselmis chuii (strain CCFM03), a green marine microalga that the Spanish company Fitoplancton Marino grows in closed outdoor photobioreactors at El Puerto de Santa María. It was authorized as a novel food in the EU in 2014, and in 2026 SuanNutra USA became its North American distributor. It is rich in the antioxidant enzyme superoxide dismutase (SOD). In three small Lonza-funded trials in exercising adults, 25 mg a day helped maintain strength and power and improved perceived recovery after hard training. All human trials so far have been small and funded or supplied by the makers.

Studied Dose 25 mg a day in most human trials, taken for 14 days to 60 days; 200 mg a day was also tested in two trials for 30 and 60 days.
Active Compound Lyophilized Tetraselmis chuii strain CCFM 03 biomass (marine microalgae); rich in superoxide dismutase (SOD).

Benefits

Explosive strength recovery after intense training

In a 5-week Lonza-funded trial in 22 regularly exercising adults, with two deliberately overloaded training weeks, jump rate of force development fell in both groups but returned to about 98% of baseline with 25 mg a day by the final test, versus about 68% with placebo. A second small Lonza trial found it prevented a drop in explosive force in a pulling test after 5 days of intense training.

Perceived recovery during hard training

In the 5-week overreaching trial, perceived recovery scores rose about 16% from week 1 to week 6 with 25 mg a day and fell about 6% with placebo, a significant difference between groups. This is a self-rated outcome from one small trial funded by Lonza, which also supplied the product.

Muscle damage markers after a strenuous training event

In a 14-day Lonza-funded trial in 18 endurance-trained adults, those taking 25 mg a day kept more squat-jump power 24 hours after a strenuous cross-training event and lost less isometric strength over 48 hours than those on placebo. Blood creatine kinase, a muscle damage marker, was 14% higher with placebo. The trial was small and maker-funded.

Immune marker (salivary IgA) during intense training

In a Lonza-funded trial in healthy adults (19 of 22 finished) who took 25 mg a day for 14 days before 5 straight days of intense resistance training, salivary immunoglobulin A, an antibody on the lining of the mouth and airways, fell significantly with placebo but not with the phytoplankton. This is one marker from one small trial; colds and infections were not tracked.

Body-composition and hormonal markers in young men

In a 60-day double-blind trial in 46 healthy young men, percent muscle mass, free testosterone, IGF-1 and erythropoietin rose and percent fat mass fell within both the 25 mg and 200 mg groups, with 25 mg looking most effective. The maker supplied the algae and the study has not been repeated. These are marker changes, not proof of muscle building or hormone boosting.

Antioxidant enzyme gene expression in muscle

In a maker-funded crossover trial, 13 healthy men took 25 mg a day and a placebo for 14 days each. Muscle biopsies after the algae showed higher expression of NRF2, a master switch for antioxidant defenses, and of antioxidant enzyme genes such as glutathione peroxidase 7 and peroxiredoxin 6, than after placebo. Gene expression is a lab marker, not a measured health outcome.

Peak oxygen uptake during cycling

In a maker-funded crossover trial in 13 recreationally active men, peak oxygen uptake rose after 14 days of 25 mg a day compared with before it but not after placebo, although after supplementation the two conditions did not differ significantly and time to exhaustion was no different from placebo. A 30-day trial in 32 amateur soccer players taking 200 mg a day also reported a within-group rise.

Grown in closed photobioreactors (sourcing attribute)

TetraSOD is grown by Fitoplancton Marino in closed outdoor photobioreactors near the Spanish coast and freeze-dried as whole algal biomass, so it contains no animal ingredients. It has been authorized in the EU as a novel food since 2014 and for food supplements since 2017. This is a sourcing and regulatory attribute, not a health benefit.

Mechanism of action

1

Superoxide dismutase (SOD) and indirect antioxidant action

TetraSOD is grown to be rich in superoxide dismutase (SOD), an enzyme that converts the superoxide radical into hydrogen peroxide. A review by the maker and its academic partners proposes that, once eaten, it works mainly as an indirect antioxidant, switching on the body's own antioxidant defenses through NRF2 and SIRT1 rather than scavenging radicals directly.

2

Inflammatory cytokines in animal studies

In exercising rats, the phytoplankton lowered the inflammatory signals TNF-alpha and IL-1 beta in muscle and blood and lowered malondialdehyde, a marker of oxidative damage, in muscle. The maker's review describes it as raising anti-inflammatory and lowering pro-inflammatory signals. These are animal findings.

3

Whole-algae nutrient content

As a whole dried alga it also contains protein, fats, vitamins and minerals, but at 25 mg a day these amounts are nutritionally negligible. The proposed effects are attributed to its enzyme activity and other bioactive compounds rather than to its nutrient content.

4

Hormonal-marker changes in one trial

In one 60-day trial in young men, erythropoietin, IGF-1 and free testosterone rose within the supplemented groups. How the alga might cause this is unknown, and these marker changes have not been repeated or linked to gains in muscle or performance.

5

Immune markers under exercise stress

Hard training can temporarily lower salivary IgA, an antibody on mucous surfaces. In one Lonza-funded trial salivary IgA held steady with the phytoplankton but fell with placebo, and the researchers propose that lower oxidative stress and inflammatory cytokines may explain this. The idea rests on one small trial and rat data.

Clinical trials

1
Five-Week Overreaching Resistance Training Trial
PubMed

Randomized, double-blind, placebo-controlled parallel trial of 25 mg a day of marine phytoplankton (Oceanix) during a 5-week resistance program with deliberate overreaching in weeks 2 and 5, run at the Applied Science and Performance Institute in Tampa and funded by Lonza, which supplied the product (Sharp et al. 2021, Int J Sports Med)

22 regularly exercising men and women aged 18 to 45 who completed the study (26 enrolled).

Perceived recovery rose about 16% from week 1 to week 6 with the phytoplankton and fell about 6% with placebo, a significant difference. Peak and mean rate of force development in a jump test fell in both groups after the overreaching weeks; at the final test the phytoplankton group was back to about 98% of baseline while placebo stayed at about 68%. A parallel rat study looked at muscle repair markers.

2
Intense Training Week Strength and Immune Marker Trial
PubMed

Randomized, double-blind, placebo-controlled parallel trial of 25 mg a day of Oceanix for 14 days before 5 consecutive days of intense resistance training, with a parallel rat study at 2.55 or 5.1 mg/kg a day; funded by Lonza and separate from the 5-week trial (Sharp et al. 2021, Phys Act Nutr)

22 healthy men and women enrolled in the human trial and 19 completed it; rats in four groups of 7.

The phytoplankton group avoided the significant drop in isometric peak rate of force development seen with placebo. Salivary immunoglobulin A fell significantly after training with placebo but not with the phytoplankton. In exercising rats it lowered TNF-alpha and IL-1 beta in muscle and blood and lowered muscle malondialdehyde.

3
Sixty-Day Body Composition and Hormone Marker Trial
PubMed

Double-blind, placebo-controlled trial of 25 mg or 200 mg a day of Tetraselmis chuii or a lactose placebo for 60 days, with tests at baseline, month 1, month 2 and 30 days after stopping; Fitoplancton Marino supplied the algae (García et al. 2022, Int J Environ Res Public Health)

46 healthy young men with an average age of about 20 to 21 (16 placebo, 15 in each dose group).

Within both supplemented groups, percent muscle mass, erythropoietin, IGF-1, free testosterone, white cells, neutrophils and lymphocytes rose significantly, while percent fat mass, platelets, hematocrit and mean corpuscular hemoglobin fell. The authors judged 25 mg a day the most effective dose. These are marker changes from one study and were not linked to performance.

4
Repeated-Bout Muscle Damage Trial in Endurance Athletes
PubMed

Randomized, double-blind, placebo-controlled parallel trial of 25 mg a day of Oceanix for 14 days, with a strenuous cross-training event on day 12 and testing 24 and 48 hours later, plus a parallel rat study; funded by Lonza (Sharp et al. 2020, Nutrients)

18 endurance-trained adults running about 30 miles a week who completed the study, 9 per group (20 enrolled).

Squat-jump power was 15% lower with placebo than with the phytoplankton 24 hours after the event, isometric strength fell more with placebo (by 12%) from before to 48 hours after, and creatine kinase, a muscle damage marker, was 14% higher with placebo. In rats, muscle antioxidant enzyme capacity rose with dose.

5
Crossover Trial of Aerobic Capacity and Muscle Gene Expression
PubMed

Two randomized, double-blind, placebo-controlled crossover experiments of 25 mg a day of Tetraselmis chuii for 14 days per condition, funded by Fitoplancton Marino, whose staff are co-authors (Cocksedge et al. 2025, Antioxidants (Basel))

Two separate groups of recreationally active healthy men, 13 completing each experiment (15 recruited to each).

Peak oxygen uptake in a cycling test rose after the algae compared with before it (p = 0.013) but not after placebo, with a significant supplement by time interaction; after supplementation the two conditions did not differ significantly (p = 0.11), and time to exhaustion and blood lactate did not differ between algae and placebo. Muscle biopsies showed higher expression of NRF2, SIRT1 and antioxidant enzyme genes such as GPX7, GSR, GSTM3 and PRDX6 after the algae than after placebo.

6
Thirty-Day Trial in Amateur Soccer Players
PubMed

Double-blind, placebo-controlled trial of 200 mg a day of Tetraselmis chuii or a lactose placebo for 30 days; Fitoplancton Marino supplied the algae (Toro et al. 2020, Int J Environ Res Public Health)

32 amateur soccer players aged about 22, 16 per group.

In the supplemented group, relative maximum oxygen consumption rose by about 6%, heart rate during the treadmill test fell and hemoglobin rose, while hematocrit and mean platelet volume fell. The abstract reports these as changes within the supplemented group rather than as differences from placebo.

Side effects and drug interactions

Common Potential side effects

In a 90-day rat feeding study, no treatment-related adverse effects were seen at doses up to 2,500 mg per kg of body weight a day.
Human trials so far have been small and lasted 60 days or less, so long-term safety is not established.
Authorized in the EU as a novel food since 2014 and for use in food supplements since 2017.
People allergic to fish, shellfish, algae or seaweed were excluded from the Lonza trials; anyone with these allergies should check with a clinician first.
Pregnancy and breastfeeding: no human safety data; ask a clinician before use.

Important Drug interactions

Drug interactions have not been studied in people.
Immunosuppressants: the ingredient may affect immune markers, so ask your prescriber before combining.
NSAIDs: trial participants were asked not to use them, so combined use has not been studied.
Antioxidant supplements: the Lonza trials excluded people already taking them, so combined use has not been studied.

Frequently asked questions about Oceanix™ / TetraSOD® (Tetraselmis chuii Marine Microalgae — Fitoplancton Marino)

What is Oceanix / TetraSOD?

Oceanix™ is the name Lonza used when it launched this marine phytoplankton ingredient in the US and Canada in 2019. The ingredient is TetraSOD®, freeze-dried Tetraselmis chuii (strain CCFM03), a green marine microalga that the Spanish company Fitoplancton Marino grows in closed outdoor photobioreactors at El Puerto de…

What is Oceanix / TetraSOD used for?

Oceanix / TetraSOD is researched primarily for Athletic Performance, Muscle & Recovery, and Antioxidant. In a 5-week Lonza-funded trial in 22 regularly exercising adults, with two deliberately overloaded training weeks, jump rate of force development fell in both groups but returned to about 98% of baseline with 25 mg a day by the final test,…

What is the recommended dosage of Oceanix / TetraSOD?

The clinically studied dose is 25 mg a day in most human trials, taken for 14 days to 60 days; 200 mg a day was also tested in two trials for 30 and 60 days. Always follow the product label and check with a healthcare provider for personal advice.

Is Oceanix / TetraSOD safe, and does it have side effects?

Side effects and cautions reported for Oceanix / TetraSOD include: In a 90-day rat feeding study, no treatment-related adverse effects were seen at doses up to 2,500 mg per kg of body weight a day. Human trials so far have been small and lasted 60 days or less, so long-term safety is not established. It may also interact with some medications. Oceanix / TetraSOD is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Oceanix / TetraSOD interact with any medications?

Possible interactions include: Drug interactions have not been studied in people. Immunosuppressants: the ingredient may affect immune markers, so ask your prescriber before combining. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Oceanix / TetraSOD?

NutraSmarts rates the evidence for Oceanix / TetraSOD as Moderate (3 out of 5). It is backed by 6 study summaries and 8 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(8 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sharp M, Wilson J, Stefan M, Gheith R, Lowery R, Ottinger C, Reber D, Orhan C, Sahin N, Tuzcu M, Durkee S, Saiyed Z, Sahin K. Marine phytoplankton improves recovery and sustains immune function in humans and lowers proinflammatory immunoregulatory cytokines in a rat model. Phys Act Nutr. 2021;25(1):42-55. doi: 10.20463/pan.2021.0007.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 22 healthy adults (19 completed): 25 mg a day of Oceanix for 14 days before 5 days of intense resistance training prevented the drops in isometric peak rate of force development and salivary IgA seen with placebo. In exercising rats it lowered TNF-alpha, IL-1 beta and malondialdehyde. Funded by Lonza.
  2. Cocksedge SP, Infante C, Torres S, Lama C, Mantecón L, Manchado M, Acton JP, Alsharif NS, Clifford T, Wadley AJ, Ferguson RA, Bishop NC, Martin NRW, Bailey SJ. Tetraselmis chuii Supplementation Increases Skeletal Muscle Nuclear Factor Erythroid 2-Related Factor 2 and Antioxidant Enzyme Gene Expression, and Peak Oxygen Uptake in Healthy Adults: A Randomised Crossover Trial. Antioxidants (Basel). 2025;14(4):435. doi: 10.3390/antiox14040435.PubMedUsed to support: Randomized, double-blind crossover trial in healthy men: 14 days of 25 mg a day raised peak oxygen uptake compared with before supplementation (after supplementation it did not differ significantly from placebo) and increased muscle expression of NRF2, SIRT1 and antioxidant enzyme genes. Time to exhaustion did not differ from placebo. Funded by Fitoplancton Marino, whose staff are co-authors.
  3. Cocksedge SP, Mantecón L, Castaño E, Infante C, Bailey SJ. The Potential of Superoxide Dismutase-Rich Tetraselmis chuii as a Promoter of Cellular Health. Int J Mol Sci. 2025;26(4):1693. doi: 10.3390/ijms26041693.PubMedUsed to support: Narrative review by Loughborough University researchers and Fitoplancton Marino staff. It notes EU novel food authorization in 2014 and food supplement authorization in 2017, and proposes that SOD-rich Tetraselmis chuii acts as an indirect antioxidant through NRF2 and SIRT1 and shifts inflammatory signals; the authors call these observations preliminary.
  4. García Á, Toro-Román V, Siquier-Coll J, Bartolomé I, Muñoz D, Maynar-Mariño M. Effects of Tetraselmis chuii Microalgae Supplementation on Anthropometric, Hormonal and Hematological Parameters in Healthy Young Men: A Double-Blind Study. Int J Environ Res Public Health. 2022;19(10):6060. doi: 10.3390/ijerph19106060.PubMedUsed to support: Double-blind, placebo-controlled trial in 46 healthy young men taking 25 or 200 mg a day for 60 days: percent muscle mass, free testosterone, IGF-1 and erythropoietin rose and percent fat mass fell within the supplemented groups, with 25 mg judged most effective. Fitoplancton Marino supplied the algae.
  5. Sharp MH, Sahin K, Stefan MW, Gheith RH, Reber DD, Ottinger CR, Orhan C, Tuzcu M, Sahin N, Lowery RP, Durkee S, Wilson JM. Marine Phytoplankton Improves Exercise Recovery in Humans and Activates Repair Mechanisms in Rats. Int J Sports Med. 2021;42(12):1070-1082. doi: 10.1055/a-1320-1061.PubMedUsed to support: In 22 regularly exercising adults aged 18 to 45 on a 5-week resistance program built to cause overreaching, 25 mg a day of marine phytoplankton (Oceanix) improved perceived recovery at the end, and rate of force development returned to baseline while it stayed lower on placebo; a parallel rat study looked at muscle repair markers. Lonza supplied the product and funded the study.
  6. Sharp M, Sahin K, Stefan M, Orhan C, Gheith R, Reber D, Sahin N, Tuzcu M, Lowery R, Durkee S, Wilson J. Phytoplankton Supplementation Lowers Muscle Damage and Sustains Performance across Repeated Exercise Bouts in Humans and Improves Antioxidant Capacity in a Mechanistic Animal. Nutrients. 2020;12(7):1990. doi: 10.3390/nu12071990.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 18 endurance-trained adults: 25 mg a day of Oceanix for 14 days preserved squat-jump power and isometric strength and kept creatine kinase lower after a strenuous cross-training event than placebo. In rats, muscle antioxidant capacity rose with dose. Funded by Lonza.
  7. Toro V, Siquier-Coll J, Bartolomé I, Robles-Gil MC, Rodrigo J, Maynar-Mariño M. Effects of Tetraselmis chuii Microalgae Supplementation on Ergospirometric, Haematological and Biochemical Parameters in Amateur Soccer Players. Int J Environ Res Public Health. 2020;17(18):6885. doi: 10.3390/ijerph17186885.PubMedUsed to support: Double-blind, placebo-controlled trial in 32 amateur soccer players taking 200 mg a day or placebo for 30 days: maximum oxygen consumption and hemoglobin rose and heart rate fell within the supplemented group. Fitoplancton Marino supplied the algae.
  8. Mantecón L, Moyano R, Cameán AM, Jos A. Safety assessment of a lyophilized biomass of Tetraselmis chuii (TetraSOD®) in a 90 day feeding study. Food Chem Toxicol. 2019;133:110810. doi: 10.1016/j.fct.2019.110810.PubMedUsed to support: 90-day oral toxicity study in rats (OECD 408): no treatment-related deaths, clinical signs or adverse effects at 625, 1,667 or 2,500 mg/kg a day; the no-adverse-effect level was above 2,500 mg/kg a day. The first author works for Fitoplancton Marino.